Omicron may not evade all monoclonal antibodies, lab study suggests
Several past studies have shown that such antibodies are unsuccessful in neutralising Omicron
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVID-19 study
Virtual clinical trials would have a tremendous advantage in expanding the reach of clinical trials
Suneela Thatte, VP and Head - R&D Solutions India, IQVIA speaks on the challenges faced by CROs due to the pandemic, the…
AbbVie, Amgen and Takeda jointly study impact of anti-inflammatory drugs in COVID-19 treatment
I-SPY COVID will evaluate the impact of cenicriviroc, otezla, and firazyr on inflammatory response in severely ill, hospitalised…